Allogene Therapeutics Price Chart
Allogene Therapeutics Volume Chart
Allogene Therapeutics Market Segments
Premarket
-0.08(-3.13%)
| Open | $2.56 |
|---|---|
| Close | $2.48 |
| Low | $2.43 |
| Low Change | -0.13 (-5.08%) |
| High | $2.56 |
| High Change | +0.00 (+0.00%) |
| Range | $0.13 |
| Volume | 6.144K |
| Dollar Volume | $15.24K |
After Hours Yesterday
+0.06(+2.44%)
| Open | $2.47 |
|---|---|
| Close | $2.53 |
| Low | $2.47 |
| Low Change | 0.00 (0.00%) |
| High | $2.64 |
| High Change | +0.17 (+6.88%) |
| Range | $0.17 |
| Volume | 26.527K |
| Dollar Volume | $67.12K |
Regular Trading Hours Yesterday
-0.09(-3.32%)
| Open | $2.56 |
|---|---|
| Close | $2.48 |
| Low | $2.41 |
| Low Change | -0.15 (-5.82%) |
| High | $2.58 |
| High Change | +0.02 (+0.78%) |
| Range | $0.17 |
| Volume | 3.071M |
| Dollar Volume | $7.60M |
Premarket Yesterday
-0.01(-0.38%)
| Open | $2.62 |
|---|---|
| Close | $2.61 |
| Low | $2.60 |
| Low Change | -0.02 (-0.76%) |
| High | $2.65 |
| High Change | +0.03 (+1.15%) |
| Range | $0.05 |
| Volume | 10.439K |
| Dollar Volume | $27.25K |
Allogene Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.53 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.54 |
| 20 Day Moving Average (SMA20) | $2.36 |
| 50 Day Moving Average (SMA50) | $1.90 |
| 100 Day Moving Average (SMA100) | $1.61 |
| 200 Day Moving Average (SMA200) | $1.42 |
Allogene Therapeutics Statistics
| Average Volume (30 Days) | 5.86M |
|---|---|
| P/E Ratio (Current) | -2.80 |
| EPS (Current) | -$0.94 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$158.99M |
| Cash Ratio | 1.19 |
| Current Ratio | 8.19 |
| Quick Ratio | 8.19 |
| Debt to Equity | 0.00 |
| Enterprise Value | $553.23M |
| EV to EBITDA | -2.60 |
| EV to Sales | — |
| Price to Book | 1.87 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.48% |
| Return on Equity | -0.67% |
Allogene Therapeutics Stock Splits
There have been no stock splits for Allogene Therapeutics (ALLO).
Allogene Therapeutics Dividends
There have been no dividends for Allogene Therapeutics (ALLO).